Further delineation of the phenotypic and metabolomic profile of ALDH1L2 ‐related neurodevelopmental disorder
Clinical Genetics · 2024-05 · 105 (5) · 488-498
DOI: 10.1111/cge.14479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 09.01.2024. Verfasst von Mikyoung You und 11 weiteren Autor:innen. Beteiligte Einrichtung: UNC Nutrition Research Institute, Kannapolis, North Carolina, USA. Hauptthemen laut MEDLINE: Oxidoreductases Acting on CH-NH Group Donors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIH HHS.
Abstract (Originalsprache)
ALDH1L2, a mitochondrial enzyme in folate metabolism, converts 10‐formyl‐THF (10‐formyltetrahydrofolate) to THF (tetrahydrofolate) and CO 2 . At the cellular level, deficiency of this NADP + ‐dependent reaction results in marked reduction in NADPH/NADP + ratio and reduced mitochondrial ATP. Thus far, a single patient with biallelic ALDH1L2 variants and the phenotype of a neurodevelopmental disorder has been reported. Here, we describe another patient with a neurodevelopmental disorder associated with a novel homozygous missense variant in ALDH1L2 , Pro133His. The variant caused marked reduction in the ALDH1L2 enzyme activity in skin fibroblasts derived from the patient as probed by 10‐FDDF, a stable synthetic analog of 10‐formyl‐THF. Additional associated abnormalities in these fibroblasts include reduced NADPH/NADP + ratio and pool of mitochondrial ATP, upregulated autophagy and dramatically altered metabolomic profile. Overall, our study further supports a link between ALDH1L2 deficiency and abnormal neurodevelopment in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UNC Nutrition Research Institute, Kannapolis, North Carolina, USA.
- Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center (KFSHRC), Riyadh, Saudi Arabia.
- Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina, USA.
- Metabolomics Section, Department of Clinical Genomics, Center for Genome Medicine, King Faisal Specialist Hospital and Research Center (KFSHRC), Riyadh, Saudi Arabia.
- Department of Biochemistry and Molecular Medicine, College of Medicine, Al Faisal University, Riyadh, Saudi Arabia.
ORCID-Profile: Fowzan S Alkuraya, Sergey A Krupenko
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
You, M., Shamseldin, H. E., Fogle, H. M., Rushing, B. R., AlMalki, R. H., Jaafar, A., Hashem, M., Abdulwahab, F., Abdel Rahman, A. M., Krupenko, N. I., Alkuraya, F. S., & Krupenko, S. A. (2024). Further delineation of the phenotypic and metabolomic profile of ALDH1L2 ‐related neurodevelopmental disorder. Clinical Genetics, 105(5), 488-498. https://doi.org/10.1111/cge.14479
Vancouver
You M, Shamseldin HE, Fogle HM, Rushing BR, AlMalki RH, Jaafar A, et al. Further delineation of the phenotypic and metabolomic profile of ALDH1L2 ‐related neurodevelopmental disorder. Clinical Genetics. 2024;105(5):488-498. doi:10.1111/cge.14479
BibTeX
@article{You2024,
author = {You, Mikyoung and Shamseldin, Hanan E and Fogle, Halle M and Rushing, Blake R and AlMalki, Reem H and Jaafar, Amal and Hashem, Mais and Abdulwahab, Firdous and Abdel Rahman, Anas M and Krupenko, Natalia I and Alkuraya, Fowzan S and Krupenko, Sergey A},
title = {Further delineation of the phenotypic and metabolomic profile of ALDH1L2 ‐related neurodevelopmental disorder},
journal = {Clinical Genetics},
year = {2024},
volume = {105},
number = {5},
pages = {488--498},
doi = {10.1111/cge.14479}
}
EUVIMED